z-logo
Premium
Suspected pulmonary embolism in patients with pulmonary fibrosis: Discordance between ventilation/perfusion SPECT and CT pulmonary angiography
Author(s) -
Leuschner Gabriela,
Wenter Vera,
Milger Katrin,
Zimmermann Gregor S.,
Matthes Sandhya,
Meinel Felix G.,
Lehner Sebastian,
Neurohr Claus,
Behr Jürgen,
Kneidinger Nikolaus
Publication year - 2016
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.12797
Subject(s) - medicine , pulmonary embolism , pulmonary angiography , radiology , perfusion , pulmonary fibrosis , pulmonary infarction , lung
Background and Objective Pulmonary embolism (PE) is a common differential diagnosis in patients with pulmonary fibrosis presenting with a clinical deterioration. Both ventilation/perfusion (V/Q)‐single photon emission computed tomography (SPECT) and computed tomographic pulmonary angiography (CTPA) are routinely used to detect PE. However, the value of V/Q‐SPECT and CTPA in this scenario has not been studied so far. We aimed to investigate the concordance of V/Q‐SPECT and CTPA in patients with pulmonary fibrosis and suspicion of pulmonary embolism. Methods A total of 22 consecutive patients with pulmonary fibrosis and clinical deterioration who underwent both V/Q‐SPECT and CTPA were included in the study and analyzed for the presence of pulmonary embolism. Results Nine of 22 patients (41%) had evidence for pulmonary embolism in V/Q‐SPECT, and two of these patients had matching evidence for pulmonary embolism in CTPA. In the other seven patients with positive findings in V/Q‐SPECT, no evidence of pulmonary embolism was found in CTPA. None of the 13 patients with a negative V/Q‐SPECT had evidence for pulmonary embolism in CTPA. Conclusion In patients with pulmonary fibrosis and suspected pulmonary embolism, pulmonary embolism is detected more frequently by V/Q‐SPECT than by CTPA. Thromboembolic disease is identified on CTPA only in a minority of patients with positive findings on V/Q‐SPECT. When making treatment decisions, clinicians should be aware of the high rate of discordant findings in V/Q‐SPECT and CTPA in this specific patient population.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom